Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States.
Loft MD, Berg KD, Kjaer A, Iversen P, Ferrari M, Zhang CA, Brasso K, Brooks JD, Røder MA. Loft MD, et al. Clin Genitourin Cancer. 2017 Sep 6:S1558-7673(17)30269-0. doi: 10.1016/j.clgc.2017.08.014. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28988695
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection.
Loft M, Carlsen EA, Johnbeck CB, Johannesen HH, Binderup T, Pfeifer A, Mortensen J, Oturai P, Loft A, Berthelsen AK, Langer SW, Knigge U, Kjaer A. Loft M, et al. Among authors: loft a. J Nucl Med. 2021 Jan;62(1):73-80. doi: 10.2967/jnumed.120.244509. Epub 2020 May 22. J Nucl Med. 2021. PMID: 32444370 Free article. Clinical Trial.
Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume.
Carlsen EA, Johnbeck CB, Loft M, Pfeifer A, Oturai P, Langer SW, Knigge U, Ladefoged CN, Kjaer A. Carlsen EA, et al. Among authors: loft m. J Nucl Med. 2021 Nov;62(11):1564-1570. doi: 10.2967/jnumed.120.258392. Epub 2021 Feb 26. J Nucl Med. 2021. PMID: 33637589 Free PMC article.
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Virgolini I, Bahri S, Kjaer A, Grønbæk H, Iversen P, Carlsen EA, Loft M, Knigge U, Maffey-Steffan J, Powell C, Miller CG, Rohban T, McEwan S, Czernin J. Virgolini I, et al. Among authors: loft m. J Nucl Med. 2022 Mar;63(3):376-383. doi: 10.2967/jnumed.121.261936. Epub 2021 Jul 2. J Nucl Med. 2022. PMID: 34215673 Free PMC article. Clinical Trial.
74 results